Aquatic Capital Management LLC Purchases 34,108 Shares of FMC Co. (NYSE:FMC)

Aquatic Capital Management LLC grew its stake in FMC Co. (NYSE:FMC - Free Report) by 55.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,990 shares of the basic materials company's stock after purchasing an additional 34,108 shares during the period. Aquatic Capital Management LLC owned about 0.08% of FMC worth $4,666,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Golden State Wealth Management LLC acquired a new stake in shares of FMC during the 4th quarter valued at about $29,000. EverSource Wealth Advisors LLC boosted its position in shares of FMC by 217.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 746 shares of the basic materials company's stock valued at $36,000 after acquiring an additional 511 shares in the last quarter. Resona Asset Management Co. Ltd. acquired a new stake in shares of FMC during the 4th quarter valued at about $37,000. IFP Advisors Inc boosted its position in shares of FMC by 65.3% during the 4th quarter. IFP Advisors Inc now owns 959 shares of the basic materials company's stock valued at $47,000 after acquiring an additional 379 shares in the last quarter. Finally, Principal Securities Inc. boosted its position in shares of FMC by 34.7% during the 4th quarter. Principal Securities Inc. now owns 990 shares of the basic materials company's stock valued at $48,000 after acquiring an additional 255 shares in the last quarter. 91.86% of the stock is currently owned by institutional investors and hedge funds.

FMC Price Performance

Shares of NYSE FMC traded down $3.52 during mid-day trading on Thursday, reaching $38.40. The company had a trading volume of 4,021,197 shares, compared to its average volume of 2,056,804. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.24 and a current ratio of 1.64. FMC Co. has a one year low of $32.83 and a one year high of $68.72. The firm has a market cap of $4.80 billion, a price-to-earnings ratio of 14.12, a PEG ratio of 1.90 and a beta of 0.83. The business's 50-day simple moving average is $39.49 and its 200 day simple moving average is $48.67.

FMC (NYSE:FMC - Get Free Report) last released its earnings results on Wednesday, April 30th. The basic materials company reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.10. FMC had a return on equity of 9.67% and a net margin of 8.03%. The firm had revenue of $791.40 million for the quarter, compared to analysts' expectations of $783.70 million. During the same quarter in the previous year, the business posted $0.36 earnings per share. The business's revenue for the quarter was down 13.8% on a year-over-year basis. On average, research analysts predict that FMC Co. will post 3.48 earnings per share for the current fiscal year.

FMC Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 17th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 6.04%. The ex-dividend date of this dividend is Monday, June 30th. FMC's payout ratio is 85.29%.

Insider Activity

In other FMC news, insider Ronaldo Pereira acquired 5,600 shares of the company's stock in a transaction on Tuesday, March 4th. The shares were purchased at an average cost of $35.77 per share, with a total value of $200,312.00. Following the completion of the purchase, the insider now owns 48,837 shares of the company's stock, valued at approximately $1,746,899.49. This represents a 12.95 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Carol Anthony Davidson acquired 6,000 shares of the company's stock in a transaction on Wednesday, March 5th. The stock was acquired at an average cost of $37.33 per share, for a total transaction of $223,980.00. Following the completion of the purchase, the director now directly owns 6,000 shares of the company's stock, valued at approximately $223,980. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 0.67% of the company's stock.

Analysts Set New Price Targets

FMC has been the topic of a number of research analyst reports. Barclays decreased their price target on FMC from $65.00 to $48.00 and set an "overweight" rating on the stock in a research report on Friday, February 7th. Mizuho upgraded FMC from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a research report on Friday, April 25th. Royal Bank of Canada lowered FMC from an "outperform" rating to a "sector perform" rating and decreased their price objective for the company from $78.00 to $47.00 in a research report on Wednesday, February 5th. Vertical Research upgraded FMC to a "hold" rating in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company decreased their price objective on FMC from $43.00 to $41.00 and set an "equal weight" rating on the stock in a research report on Monday, April 21st. One analyst has rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $49.15.

About FMC

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control.